BlackRock Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

BlackRock Group’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.03M	Buy	81,640 +27,724	+51%	+$516K	﹤0.01%	2117
2016 Q3	$1.51M	Buy	53,916 +7,801	+17%	+$262K	﹤0.01%	1809
2016 Q2	$1.61M	Buy	46,115 +3,910	+9%	+$123K	﹤0.01%	1680
2016 Q1	$1.16M	Buy	42,205 +25,955	+160%	+$764K	﹤0.01%	1867
2015 Q4	$556K	Sell	16,250 -253	-2%	-$7.89K	﹤0.01%	2155
2015 Q3	$474K	Buy	16,503 +8,677	+111%	+$371K	﹤0.01%	2226
2015 Q2	$351K	Buy	7,826 +3,945	+102%	+$148K	﹤0.01%	2391
2015 Q1	$134K	Sell	3,881 -43,279	-92%	-$1.18M	﹤0.01%	2594
2014 Q4	$1.29M	Buy	+47,160	New	+$1.14M	﹤0.01%	1733

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock Group's DPLO Position: Q4 2016 in Review

BlackRock Group increased its DIPLOMAT PHARMACY, INC. (DPLO) stake by 51% in Q4 2016, buying an estimated $516K and bringing the position to 81,640 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2117.

BlackRock Group first reported a position in DPLO in Q4 2014 and has held it in 9 quarters since. The position peaked at $1.61M in Q2 2016. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

BlackRock Group held 81,640 shares of DIPLOMAT PHARMACY, INC. worth $1.03M as of Q4 2016.
BlackRock Group bought 27,724 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $516K.
DIPLOMAT PHARMACY, INC. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2117 holding.
BlackRock Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and has held it in 9 quarters since.
BlackRock Group's DIPLOMAT PHARMACY, INC. position peaked at $1.61M in Q2 2016.
174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.